This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Kei Yamanishi: Innovator in Indazole Compounds
Introduction: Kei Yamanishi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on indazole compounds. His innovative research has the potential to impact various therapeutic areas.
Latest Patents: Kei Yamanishi holds 1 patent related to indazole compounds. The patent describes compounds represented by specific formulas that exhibit β3 adrenergic receptor agonist activity. These compounds are useful as therapeutic and prophylactic agents for conditions such as diabetes mellitus, obesity, hyperlipidemia, depression, and other related diseases.
Career Highlights: Yamanishi is associated with Asahi Kasei Pharma Corporation, where he has been instrumental in advancing pharmaceutical research. His work focuses on developing new therapeutic agents that address significant health challenges.
Collaborations: Throughout his career, Kei Yamanishi has collaborated with notable colleagues, including Seiji Nakano and Taisuke Iwanami. These partnerships have fostered innovation and contributed to the success of their research endeavors.
Conclusion: Kei Yamanishi's contributions to the field of pharmaceuticals, particularly through his patent on indazole compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile